Page 2 - Biomedical Catalyst News Today

Effective treatment of AID is still a considerable area of unmet medical requirements - News - PharmaTimes

Deadline: 29-Mar-23 Investors can apply to partner with Innovate UK to invest in innovative SMEs aligned with grant funding. Innovate UK will support

Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris.

Alchemab Therapeutics and MDC have received $2.06m grant from Innovate UK to accelerate the development of disease modifying therapy

/PRNewswire/ -- Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today announced that it has been awarded...

The UK's innovation agency, Innovate UK, has awarded LabGenius Biomedical Catalyst funding to drive the development of their immunotherapy pipeline LabGenius, a pioneer in the use of machine learning

NHS patients are set to benefit from cutting-edge new treatments and technologies as the government introduces a Vaccine Taskforce style approach to tackling some of the biggest public health challenges facing the UK.

Patients will benefit from cutting-edge new treatments as the government introduces a Vaccine Taskforce style approach to tackling health challenges.

Start-up Neobe Therapeutics has raised £520K towards financing its endeavours to reduce barriers to  immunotherapy in cancer patients with so...

Cambridge and Stevenage, United Kingdom, 30th June 2022 / Sciad Newswire / NRG Therapeutics Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, and Domainex Ltd., today announce a collaboration focused on developing novel small molecule disease-modifying medicines for the treatment of Parki...